Explanation to Bollinger's Bands

Bollinger Bands was created by John Bollinger in the early 1980s, its purpose is to define price action relative to the assets highs and lows. This technical indicator is used to identify buy and sell signals and has proven very well in doing so.

Bollinger Bands consist of a set of three curves drawn in relation to securities prices. The middle band is a measure of the intermediate-term trend, usually a simple moving average, that serves as the base for the upper and lower bands. The interval between the upper and lower bands and the middle band is determined by volatility, typically the standard deviation of the same data that were used for the average. StockInvest.us uses Bollingers suggested 20 day average.

Middle Bollinger Band = 20-period simple moving average
Upper Bollinger Band = Middle Bollinger Band + 2 * 20-period standard deviation
Lower Bollinger Band = Middle Bollinger Band - 2 * 20-period standard deviation

BandWidth defines the current width of the band.
%b defines the current position within the band.

BandWidth = (Upper Bollinger Band - Lower Bollinger Band) / Middle Bollinger Band
%b = (Last - Lower Bollinger Band) / (Upper Bollinger Band - Lower Bollinger Band)

Live Samples:

Bollinger Bottleneck Buy Pattern 1
Bollinger Bottleneck Buy Pattern 2
Bollinger Bottleneck Sell Pattern

Bottlenecks in bandwidth indicate an upcoming change. Break up through the moving average line or continuous movements above the moving average line indicate a break up, and vice versa.

Source: http://www.bollingerbands.com

RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of INMB
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Inmune stock downgraded from Hold/Accumulate to Sell Candidate after Thursday trading session.
(Updated on Mar 28, 2024)

Sell candidate since Mar 28, 2024 PDF

The Inmune stock price gained 1.03% on the last trading day (Thursday, 28th Mar 2024), rising from $11.63 to $11.75. During the last trading day the stock fluctuated 6.83% from a day low at $11.28 to a day high of $12.05. The price has been going up and down for this period, and there has been a 2.71% gain for the last 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 4 thousand more shares were traded than the day before. In total, 96 thousand shares were bought and sold for approximately $1.13 million.

The stock is moving within a very wide and horizontal trend and further movements within this trend can be expected. Given the current horizontal trend, you can expect Inmune stock with a 90% probability to be traded between $10.53 and $14.01 at the end of this 3-month period. A break of a horizontal trend is often followed by a large increase in the volume, and stocks seldom manage to go directly from the bottom of a trend up to the top. Stocks turning up in the middle of a horizontal trend are therefore considered to be potential runners.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

INMB Signals & Forecast

There are mixed signals in the stock today. The Inmune stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $11.81 and $12.22. A break-up above any of these levels will issue buy signals. A buy signal was issued from a pivot bottom point on Tuesday, March 19, 2024, and so far it has risen 7.40%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Inmune has increased volume and follows the last lift in the price. This is considered to be a technical positive sign as volume should follow the price-formation. Higher liquidity also reduces the general risk.

Support, Risk & Stop-loss for Inmune stock

Inmune finds support from accumulated volume at $11.63 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.770 between high and low, or 6.83%. For the last week, the stock has had daily average volatility of 6.93%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (INMB) For The Upcoming Trading Day Of Monday 1st

For the upcoming trading day on Monday, 1st we expect Inmune Bio Inc. to open at $11.69, and during the day (based on 14 day Average True Range), to move between $10.97 and $12.53, which gives a possible trading interval of +/-$0.777 (+/-6.62%) up or down from last closing price. If Inmune Bio Inc. takes out the full calculated possible swing range there will be an estimated 13.23% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $11.63 (1.02%) than the resistance at $12.18 (3.66%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Inmune Bio Inc. stock A Buy?

Inmune holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Hold/Accumulate to a Sell candidate.

Current score: -1.769 Sell Candidate Downgraded

Predicted Opening Price for Inmune Bio Inc. of Monday, April 1, 2024

Fair opening price April 1, 2024 Current price
$11.69 ( 0.482%) $11.75

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for INMB

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 12.46 6.07 %
R2 12.17 3.57 %
R1 11.99 2.02 %
Current price: 11.75
Support S1 11.40 -2.99 %
S2 11.22 -4.53 %
S3 10.92 -7.04 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 14.00 19.15 %
R2 12.90 9.79 %
R1 12.18 3.66 %
Current price 11.75
Support S1 11.63 -1.02%
S2 11.58 -1.45%
S3 10.53 -10.38%

FAQ

What is the symbol for Inmune Stock and on which exchange is it traded?
The symbol for Inmune is INMB and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Inmune Stock?
Inmune holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Hold/Accumulate to a Sell candidate.

How to buy Inmune Stock?
Inmune Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Inmune Stock.

What's the current price of Inmune Stock?
As of the end of day on the 2024-03-28, the price of an Inmune (INMB) share was $11.75.

What is the 52-week high and low for Inmune Stock?
The 52-week high for Inmune Stock is $14.74 and the 52-week low is $5.87.

What is the market capitalization of Inmune Stock?
As of the 2024-03-28, the market capitalization of Inmune is 211.755M.

When is the next earnings date for Inmune?
The upcoming earnings date for Inmune is May 01, 2024.
Click to get the best stock tips daily for free!

About Inmune Bio Inc.

Inmune INmune Bio, Inc., a clinical-stage immunotherapy company, focuses on developing drugs to reprogram the patient's innate immune system to treat disease. The company develops and commercializes product candidates to treat hematologic malignancies, solid tumors, and chronic inflammation. Its development programs include INKmune, which focuses on treating women with relapse refractory ovarian carcinoma and patients with high-risk myelodysplastic synd... INMB Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT